Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Fragile X Syndrome

What is Fragile X Syndrome?

Fragile X Syndrome is an inherited genetic disorder caused by a mutation in the FMR1 gene that affects nearly 1 in every 4,000 males and 1 in every 6,000 to 8,000 females in the USA. The FMR1 gene, located on the X chromosome, codes for the FMRP protein, which plays a vital role in the central nervous system, particularly in the development of neurons in the brain. Therefore, lack of fully functional FMRP protein results in the characteristic symptoms of Fragile X Syndrome, which include developmental delay, learning disabilities, and social/behavioral problems. Given that the condition is inherited on the X chromosome, females are more likely to be carriers of the condition. Symptoms are less pronounced in females with the condition than in males

 

The area of the genome immediately preceding the coding region of the FMR1 gene typically has 5 to 44 CGG DNA nucleotide sequence repeats in unaffected individuals, while affected individuals with Fragile X have the CGG sequence repeated up to 200 times. However, Fragile X Syndrome occurs on a spectrum, with the number of repeats varying from individual to individual. When individuals are located within the “gray zone” (an increased amount of repeats but not dramatically larger numbers), they are considered to have a “premutation.” 


In order to diagnose the condition, molecular genetic testing is conducted to gauge the number of CGG repeats in the FMR1 gene. While there is no cure for the condition currently, there are numerous treatments for Fragile X Syndrome that help alleviate symptoms associated with the condition. For example, behavioral modification programs, speech therapy, and sensory integration training allow children with the disorder to live normal lifestyles. Affected individuals typically have normal lifespans if they keep up a healthy and active lifestyle. However, people with Fragile X Syndrome are more prone to other medical problems that range in severity from mild ear infections to severe seizures.

 

Synonyms

  • Fragile X Syndrome
  • Martin-Bell syndrome
  • FRAXA syndrome
  • Marker X Syndrome

Fragile X Syndrome is an inherited genetic disorder caused by a mutation in the FMR1 gene that affects nearly 1 in every 4,000 males and 1 in every 6,000 to 8,000 females in the USA. The FMR1 gene, located on the X chromosome, codes for the FMRP protein, which plays a vital role in the central nervous system, particularly in the development of neurons in the brain. Therefore, lack of fully functional FMRP protein results in the characteristic symptoms of Fragile X Syndrome, which include developmental delay, learning disabilities, and social/behavioral problems. Given that the condition is inherited on the X chromosome, females are more likely to be carriers of the condition. Symptoms are less pronounced in females with the condition than in males

 

The area of the genome immediately preceding the coding region of the FMR1 gene typically has 5 to 44 CGG DNA nucleotide sequence repeats in unaffected individuals, while affected individuals with Fragile X have the CGG sequence repeated up to 200 times. However, Fragile X Syndrome occurs on a spectrum, with the number of repeats varying from individual to individual. When individuals are located within the “gray zone” (an increased amount of repeats but not dramatically larger numbers), they are considered to have a “premutation.” 


In order to diagnose the condition, molecular genetic testing is conducted to gauge the number of CGG repeats in the FMR1 gene. While there is no cure for the condition currently, there are numerous treatments for Fragile X Syndrome that help alleviate symptoms associated with the condition. For example, behavioral modification programs, speech therapy, and sensory integration training allow children with the disorder to live normal lifestyles. Affected individuals typically have normal lifespans if they keep up a healthy and active lifestyle. However, people with Fragile X Syndrome are more prone to other medical problems that range in severity from mild ear infections to severe seizures.

Acknowledgement of Fragile X Syndrome has not been added yet.

Fragile X Syndrome affects nearly 1 in every 4,000 males and 1 in every 6,000 to 8,000 females in the USA. Therefore, males are approximately twice as likely to develop the condition. However, females are about 4 times more likely to be carriers of the syndrome and are asymptomatic since the altered gene occurs on the X chromosome. Since males (XY) only have one X chromosome, it is more likely that they will develop the condition if there is a mutation inherited from the mother. This condition has been found to affect all races and ethnicities. 

Name Abbreviation
Fragile X Syndrome FXS
Martin-Bell syndrome FXS
FRAXA syndrome FXS
Marker X Syndrome FXS

Fragile X Syndrome is a condition that is caused by a genetic mutation in the FMR1 gene, found at Xq27.3 on the X chromosome. Generally, people who have the condition inherit a complete gene mutation, which means they have the sequence of CGG repeated around 200 times. For comparison, someone without the condition typically has 5 to 44 CGG repeats. Fragile X syndrome can be described as a spectrum, with a  “gray zone” characterized by 45 to 54 occurrences of the trinucleotide repeat. This modest increase of repeats is known as a “premutation”. However, as the gene is passed down through generations, the number of CGG repeats increases and the mutations become more pronounced until complete Fragile X syndrome manifests.

When the individual has Fragile X Syndrome, a post-translational process known as DNA methylation occurs in an abnormal way, during which the gene cannot produce the necessary FMRP protein. DNA methylation affects the creation of certain mRNA strands for particular proteins, and therefore, plays a large role in the inhibition of the creation of the FMRP protein. FMRP plays a vital role in the central nervous system, particularly in the development of neurons in the brain. Therefore, a lack of the FMRP protein results in the characteristic symptoms of Fragile X Syndrome.

In children, there are 3 main symptoms of Fragile X Syndrome. One of the main symptoms of the condition is developmental delay, including sitting, walking, and talking later than other children of the same age. Similarly, Fragile X Syndrome is often accompanied by social and behavioral problems. For example, affected children may have trouble paying attention, be hyperactive, or exhibit anxiety in social situations. In addition, the condition can be accompanied by learning difficulties. In affected males, some form of intellectual disability is rather common. Females, on the other hand, often have normal intellectual capacity. Many of the symptoms of Fragile X Syndrome are very similar to that of autism spectrum disorders. The physical symptoms of the condition, including flat feet, protruding ears, and a prominent chin and forehead, typically develop after affected males hit puberty. Females typically have less pronounced physical symptoms than males.

Fragile X Syndrome is typically diagnosed after the individual displays characteristic symptoms of the condition. From that point, doctors will conduct diagnostic tests to confirm the diagnosis.The condition used to be diagnosed through chromosome analysis, though now it is primarily diagnosed through molecular genetic testing. The condition is called “Fragile X Syndrome” since affected individuals possess an X chromosome that appears weak or broken. 
 

Tests to confirm Fragile X Syndrome diagnosis include:

  • Molecular genetic testing → will allow doctors to understand how many CGG repeats in the FMR1 gene are present

  • Testing to determine methylation status → evaluation of the chemical status of the FMR1 gene and the resulting production of FRMP protein

  • Chromosome analysis → previous strategy conducted to diagnose the condition; less accurate and more costly than molecular genetic testing

While there is no cure for the condition currently, there are numerous treatments for Fragile X Syndrome that help alleviate symptoms associated with the condition. Some of the more common treatments involve behavioral modification programs, speech therapy, and sensory integration training. Genetic counseling is also generally recommended to the individual and their families. Often, early intervention programs are the most effective as they aid with the child’s development and allow children to accrue social skills they may otherwise lack. There are many organizations that are currently searching for a cure for the condition. FRAXA (www.fraxa.org) is an organization that is developing investigational therapies for the condition. 

Affected individuals typically have normal lifespans if they keep up a healthy and active lifestyle. However, people with Fragile X Syndrome are more prone to other medical problems that range in severity. For example, milder problems include ear infections, which are common in affected individuals. However, more serious medical issues, such as seizures, can also affect the individual. Therefore, frequent medical check-ups are necessary to ensure the health of the individual. 

Individuals with fragile X syndrome may seek help from occupational therapists, speech pathologists, and psychologists. An occupational therapist can work with individuals on hypersensitivity and tactile defensiveness. In addition to this, the therapist can give advices and assistance on calming techniques, movement, fine motor development, and oral motor development.  A speech pathologist can help with language skills and speech (such as pronunciations). A psychologist can give support on behaviour, social emotions, education, and family.

Fragile X Syndrome. Genetic Home Reference website. Available at: http://ghr.nlm.nih.gov/condition/fragile-x-syndrome 

Fragile X Mental Retardation Syndrome. Online Mendelian Inheritance in Man (OMIM) website. Available at: http://www.omim.org/entry/300624 

Fragile X Syndrome. National Organization for Rare Disorders website.  Available at: https://rarediseases.org/rare-diseases/fragile-x-syndrome/


Hagerman R. Fragile X Syndrome. OrphaNet website. Available at: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=908.0 Accessed May 2016.

https://fragilex.org/genetics/what-defines-a-carrier/#:~:text=Male%20premutation%20carriers%2C%20because%20they,their%20risk%20of%20developing%20FXTAS.

https://www.cdc.gov/ncbddd/fxs/facts.html

Community Details Update Created by RareshareTeam
Last updated 26 Mar 2022, 11:36 PM

Posted by RareshareTeam
26 Mar 2022, 11:36 PM

Hi everyone,

The Fragile X Syndrome community details have been updated. We added more information about the cause, prevalence, symptoms, diagnosis, and treatment. Hopefully, you find it helpful. 

Community External News Link
Title Date Link
Researchers develop language test for people with Fragile X syndrome 06/01/2020
Science Brings Shortcut to Spotting 50 Rare Genetic Diseases 03/13/2022
Community Resources
Title Description Date Link

Clinical Trials


Cords registry

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.

Enrolling is easy.

  1. Complete the screening form.
  2. Review the informed consent.
  3. Answer the permission and data sharing questions.

After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.

Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.

Visit sanfordresearch.org/CoRDS to enroll.

Community Leaders

 

Expert Questions

Ask a question

Community User List

My son has Fragile X E syndrome. and BRR Syndrome. Looking for anyone that has both or know's somebody with both so I can get info on it to learn how my son think's to make life better for him....

Start a Community


Don't See Your Condition On Rareshare?

Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.

FAQ


Have questions about rareshare?

Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.


Communities

Our Communities

Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.

FIND YOUR COMMUNITY
Physicians

Our Resources

Our rare disease resources include e-books and podcasts

VIEW OUR EBOOKS

LISTEN TO OUR PODCASTS

VIEW OUR GUIDES

Leaders

Our Community Leaders

Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.